Abstract
Importance Social prescribing (SP) is a mechanism of care referring people to non-clinical forms of support and services in local communities to improve health and wellbeing. But there is much contention over whether SP is in fact provided disproportionately more to individuals who are less disadvantaged. However, a comprehensive analysis of who is receiving SP from both medical and non-medical referral routes has never been undertaken.
Objective To incorporate bespoke novel questions on SP into a nationally-representative cohort study to assess whether SP is truly reaching individuals most in need.
Design We used data from Wave 10 (2021/23) of the English Longitudinal Study of Ageing (ELSA) involving richly-phenotyped adults aged 50+ living in England. We explored how SP was patterned according to social and health inequalities, all measured in Wave 9 (2018/19; prior to the reported engagement in SP). Multiple ordinal regression models were used to explore predictors of receiving a SP referral.
Setting Community-dwelling older adults living in England
Participants 7,283 adults aged 50+ answered the self-completion questionnaire at wave 10 so were included in analyses.
Main outcomes and measures Participants were asked if they had received a referral to a wide range of community-based activities by a doctor, social worker or other health professional
Results 495 adults (6.8%) reported receiving a SP referral, and 435 (88%) accepted. Age was a significant predictor of referrals (OR 1.02, CI 1.01-1.03), but being female was not (OR 1.05, CI 0.84-1.30). Receiving benefits increased referral odds two-fold (OR 2.03, CI 1.53-2.70) and being in the lowest wealth tertile (relative to middle tertile) by 55% (CI 1.13-2.13). Education and employment status did not predict referrals. Referrals were most common for individuals with depression (OR=1.60, CI 1.20-2.12), diabetes (OR=1.52, CI 1.11-2.10), chronic pain (OR=1.57, CI 1.22-2.02), multiple long-term conditions (4+ conditions, OR=2.8, CI 1.41-5.51), and who were physically inactive (OR=1.63, CI 1.10-2.41).
Conclusions and relevance There is some initial evidence of SP referrals occurring amongst older adults in England, with high uptake amongst those referred. Promisingly, those with highest socio-economic need and most long-term health conditions particularly appear to be receiving support.
Question Who is receiving referrals to social prescribing programmes?
Findings In this analysis of a nationally representative cohort study of 7,283 richly-phenotyped adults aged 50+ living in England, SP was offered most to individuals experiencing socio-economic adversity with health needs including depression, diabetes, chronic pain, multiple long-term conditions, and those who were physically inactive.
Meaning Promisingly, older adults with highest socio-economic need and most long-term health conditions particularly appear to be receiving support through social prescribing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was funded by the Nuffield Foundation Oliver Bird Fund and Versus Arthritis OBF/FR-000023818
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data are publicly available on the UK Data Service https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=200011
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data are publicly available through the UK Data Service
https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=200011
